Ms. Bellucci joined BI – Basel as Associate Director, Brand Development in 2020, and was promoted Director in 2021. Within Brand Institute, she worked on neurology Brands such as Noxarem as well as other products in development for oncology, endocrinology, ophthalmology, gastroenterology, COVID, and rare diseases for companies in Italy, Spain, the Netherlands and Switzerland. Prior to joining Brand Institute, she was Global Category & Brand Manager Beauty at Dufry, responsible for top brand partners in the Luxury, Skincare & Cosmetic industry such as Estée Lauder, Shiseido, and La Prairie. She was also Product Manager at Sudler & Hennessey where she worked with a wide range of clients such as Pfizer, Sandoz, Ferring, Roche and Amgen in the areas of infectious diseases (Vfend & Ecalta), oncology (Avastin), urology (Leuprorelin), reproductive health (Menopur, Endometrin and Bravelle) and cardiovascular disease (Repatha). She earned a B.S. in Biotechnology and M.S. in Medical Biotechnology from University of Bicocca in Milan, Italy.
